Goldman Sachs
June 5, 2026
Philips: Framing The Opportunity Of Potential Return To US Sleep
Sector ReportEquitiesHealth Care
This report examines the investment case for Philips, highlighting the potential for a return to the US Sleep systems market as a catalyst for growth. Goldman Sachs maintains a Buy rating on the stock with a €31.50 price target.
Key Takeaways
- 1.Philips is currently rated Buy with a price target of €31.50, supported by robust operating performance and potential upside from a return to the US sleep systems market.
- 2.A potential return to the US sleep market could drive incremental EBITA and EPS upside of 2-8% by FY27-FY29, depending on the speed and scale of market share recapture.
- 3.The DME market structure, dominated by four major players, is highly consolidated and supportive of a potential rapid re-entry for Philips.
Table of Contents
- Philips (PHG.AS)
- 6 key charts
- June 2021 product recall in US Sleep was the start of a challenging period for Philips
- Return to market OUS seems to be building momentum
- Return to US sleep systems could present incremental upside to our estimates and company guidance
- DME market structure seems conducive to rebuilding presence
- Framing the opportunity - What could return to US sleep look like for growth and EBITA?
- Other consideration...
- Incremental revenue with attractive drop through could drive upside to our group EBIT and EPS forecasts
- DMEs market structure supportive of competition and scale distribution
- Other market share considerations
- Valuation
- Disclosure Appendix
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Richard Felton, CFALauren Mitchell
Securities
PHG.ASRMD.AXAHCOSiemens Healthineers
Themes
US Market Regulatory RemediationMedTech Market Consolidation
Regions
EuropeUnited StatesNetherlands
